Navigation Links
A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
Date:8/30/2007

lia, is developing a range of therapeutics across the fields of oncology, cardiovascular disease and inflammatory diseases. More information on phenoxodiol and on the Novogen group of companies can be found at http://www.marshalledwardsinc.com and http://www.novogen.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing; technological changes; government regulation; change
'/>"/>

SOURCE Marshall Edwards Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... Oct. 24, 2014  Heska Corporation (Nasdaq: ... You to Join Its Third Quarter 2014 Earnings Conference ... a.m. (MDT) / 11:00 a.m. (EDT)Where: , www.heska.com ... on the front page of this website)How:Live over the ... the address above.  Alternatively, you may use the following ...
(Date:10/25/2014)... 24, 2014  In 2008, two of Dr. Gurney,s ... multiple controlled substances, on a regular basis, that were ... Dr. Gurney was practicing "all the time" while under ... his employees said that Dr. Gurney was prone to ... Dr. Gurney,s behavior became increasingly erratic and ...
(Date:10/25/2014)... , October 24, 2014 ... ) has announced the addition of the  ... 2014"  report to their offering.  ... and Chinese Acne Medication Industry Report 2014 ... the current state of the global acne ...
Breaking Medicine Technology:Webcast Alert: Heska Announces Third Quarter 2014 Earnings Conference Call Webcast 2Doctors That Harm: The Real Stories Insurance Companies Against Prop 46 Don't Want You To Know, Part 8 of Consumer Watchdog Campaign Series 2Doctors That Harm: The Real Stories Insurance Companies Against Prop 46 Don't Want You To Know, Part 8 of Consumer Watchdog Campaign Series 3Global and Chinese Acne Medication Industry Report 2014 2Global and Chinese Acne Medication Industry Report 2014 3
... 8, 2011 Adeona Pharmaceuticals, Inc. (NYSE Amex: ... serious central nervous system diseases, announced today that it ... Award.  As an honoree, the Company is highlighted in ... featuring Adeona is available via the "Adeona in the ...
... 2011 QPS, LLC, a leading full-service GLP/GCP-compliant contract ... clinical research and development, announced the acquisition of a ... of the biotechnology company Genovate, Inc, is a full ... will retain a minority interest in Qualitix, which will ...
Cached Medicine Technology:QPS Expands Clinical Trial Services with Acquisition of Qualitix 2QPS Expands Clinical Trial Services with Acquisition of Qualitix 3
(Date:10/25/2014)... -- Arriving home safe and sound is one of the ... sure that costumes and goody bags have reflective strips that ... medicine doctor at Meadowlands Hospital Medical Center in Secaucus, N.J. ... should be flame-resistant, Davis said. He offers these others ... it on a small area of skin first to ensure ...
(Date:10/25/2014)... October 25, 2014 The ... which verifies IT-accessibility for disabled users by disabled ... logo to Mackin Educational Resources of Burnsville, ... management system and to the Minnesota Alliance for ... "Own Best Medicine" website. Both organizations ...
(Date:10/25/2014)... 25, 2014 The federal judge ... ) filed against Boston Scientific Corp. in ... Court, Southern District of West Virginia has denied ... Damages in a group of cases filed on ... on October 21st, U.S. District Judge Joseph R. ...
(Date:10/25/2014)... Steven Reinberg HealthDay ... The virus that causes common cold sores -- herpes simplex ... by Swedish researchers suggest. In fact, being a carrier ... of Alzheimer,s disease, the researchers found. "The identification ... dementia disorder is a breakthrough," said lead researcher Dr. Hugo ...
(Date:10/25/2014)... FRIDAY, Oct. 23, 2014 (HealthDay News) -- Current ... many younger postmenopausal women at risk for osteoporosis-related ... want to prevent fractures, we need tools that ... osteoporotic injuries so that we can target these ... Carolyn Crandall, professor of medicine in the division ...
Breaking Medicine News(10 mins):Health News:Tips for Safe Trick-or-Treating 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Osteoporosis Screening Guidelines May Miss Younger Women at Risk 2
... You,re driving to a restaurant for the very first time. At a ... several minutes more. Nothing in sight. The disturbing thought creeps into your ... turn?" , At what point will you make ... you are of the decision you made at the crossroads. If you ...
... Condition can damage kidneys, brain and heart, study says , , ... 50 children found that almost half of those who were ... had a significant increase in blood pressure when they ate ... "Salt sensitivity in children is low and rises with increasing ...
... for more than 7 years quadrupled chance of hip breaks, ... Canadian research shows that long-term use of proton pump inhibitors ... risk of osteoporosis-related fractures. , This is now the ... in people who use these medications. This latest study, reported ...
... (Nasdaq: STAA ), a leading developer, manufacturer ... that it will,present at the at the upcoming ... held Monday, August 18th - Tuesday, August 19th,2008 ... Barry G. Caldwell,President and Chief Executive Officer will ...
... Fort Dodge,Animal Health, a division of Wyeth (NYSE: ... owners, section on http://www.leptoinfo.com, a Web site ... owners about,Leptospirosis, a growing canine health threat., Leptospirosis ... and humans that occurs in countries around the world, ...
... 12, 2008 at 1:30 p.m. (Pacific Time); ... simultaneous webcast at http://www.adventrx.com , SAN ... a biopharmaceutical company focused on in-licensing,developing and commercializing proprietary product ... reported financial,results for the three-month and six-month periods ended June ...
Cached Medicine News:Health News:CSHL neuroscientists glimpse how the brain decides what to believe 2Health News:CSHL neuroscientists glimpse how the brain decides what to believe 3Health News:CSHL neuroscientists glimpse how the brain decides what to believe 4Health News:Low-Birth-Weight Babies at Risk for Salt Sensitivity 2Health News:Powerful Antacid Drugs Raise Fracture Risk 2Health News:Powerful Antacid Drugs Raise Fracture Risk 3Health News:STAAR Surgical to Present at the Noble Financial Equity Conference 2Health News:Fort Dodge Animal Health Announces Leptoinfo.com Now Available to Dog Owners 2Health News:ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update 2Health News:ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update 3Health News:ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update 4Health News:ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update 5Health News:ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update 6Health News:ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update 7
Forte Guide Wire w/Markers: Front line use, 1:1 torque, excellent steering and tracking, sharp vessel images, floppy and moderate support....
12mm Blades, Maximum Spread 18mm, Spring Action, Wire - Pediatric; in stainless steel...
15mm Open Blades, 30mm Maximum Blade Spread; in Titanium....
5mm Gently Curved Wing Span, With Centering Pin, Low Profile; in stainless steel....
Medicine Products: